SMS Pharmaceuticals Completes USFDA Inspection At Central Laboratory Analytical Services
ReutersJun 25, 2025 11:08 AM
June 25 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
COMPLETES USFDA INSPECTION AT CENTRAL LABORATORY ANALYTICAL SERVICES
USFDA INSPECTION CONCLUDES WITH ZERO FORM 483 OBSERVATIONS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
SoundHound Analysis: Will This Overlooked AI Stock Be the Surprise Winner of 2026?
While buying SoundHound stock, you may need to look at key indicators that will help you tell the noise from the signals.TradingKey
11 hours ago
Stock Market Crash 2026: What Fed Signals and Economic Data Mean for Investors
TradingKey - The possibility of a stock market crash occurring in 2026 is becoming increasingly likely as investor sentiment continues to decline.TradingKey
Thu, Feb 19
New Fed Chair Warsh Takes Office: Major Shift in Monetary Policy? US Dollar Short-Term Rebound, 2026 Investment Strategy Analysis
TradingKey - At the start of 2026, global financial markets witnessed a major leadership change as U.S. President Trump officially nominated Kevin Warsh as the next Federal Reserve Chair. Pending Senate confirmation, he will succeed Jerome Powell this May to lead the world’s most influential central bank.TradingKey
Thu, Feb 19
